DIA/FDA Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

返回 Agenda

Welcome Remarks and Overview of the 2017 Conference

Senior Vice President and Managing Director, DIA Americas

DIA, United States

CMC Therapeutic Area Lead

Moderna Therapeutics , United States

Pharmacologist, CDER

FDA, United States

Program Co-Chair